Coherus BioSciences Statistics

Total Valuation

CHRS has a market cap or net worth of $97.19 million. The enterprise value is $270.31 million.

Market Cap	97.19M
Enterprise Value	270.31M

Important Dates

The last earnings date was Monday, March 10, 2025, after market close.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

CHRS has 115.90 million shares outstanding. The number of shares has increased by 21.95% in one year.

Current Share Class	115.90M
Shares Outstanding	115.90M
Shares Change (YoY)	+21.95%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	58.60%
Float	114.41M

Valuation Ratios

The trailing PE ratio is 3.37.

PE Ratio	3.37
Forward PE	n/a
PS Ratio	0.37
Forward PS	0.61
PB Ratio	-0.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	9.48
EV / Sales	1.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.21

Current Ratio	1.21
Quick Ratio	0.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.94%
Return on Invested Capital (ROIC)	-25.98%
Return on Capital Employed (ROCE)	-57.00%
Revenue Per Employee	$1.17M
Profits Per Employee	$125,031
Employee Count	228
Asset Turnover	0.50
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.35% in the last 52 weeks. The beta is 0.92, so CHRS's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-65.35%
50-Day Moving Average	1.09
200-Day Moving Average	1.25
Relative Strength Index (RSI)	35.65
Average Volume (20 Days)	2,150,558

Short Selling Information

The latest short interest is 31.81 million, so 27.45% of the outstanding shares have been sold short.

Short Interest	31.81M
Short Previous Month	30.90M
Short % of Shares Out	27.45%
Short % of Float	27.81%
Short Ratio (days to cover)	18.43

Income Statement

In the last 12 months, CHRS had revenue of $266.96 million and earned $28.51 million in profits. Earnings per share was $0.25.

Revenue	266.96M
Gross Profit	149.41M
Operating Income	-94.37M
Pretax Income	-29.72M
Net Income	28.51M
EBITDA	-89.09M
EBIT	-94.37M
Earnings Per Share (EPS)	$0.25

Full Income Statement

Balance Sheet

The company has $125.99 million in cash and $298.65 million in debt, giving a net cash position of -$172.66 million or -$1.49 per share.

Cash & Cash Equivalents	125.99M
Total Debt	298.65M
Net Cash	-172.66M
Net Cash Per Share	-$1.49
Equity (Book Value)	-131.99M
Book Value Per Share	-1.14
Working Capital	58.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.44M
Capital Expenditures	n/a
Free Cash Flow	-20.44M
FCF Per Share	-$0.18

Full Cash Flow Statement

Margins

Gross margin is 55.97%, with operating and profit margins of -35.35% and 10.68%.

Gross Margin	55.97%
Operating Margin	-35.35%
Pretax Margin	10.68%
Profit Margin	10.68%
EBITDA Margin	-33.37%
EBIT Margin	-35.35%
FCF Margin	n/a

Dividends & Yields

CHRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.95%
Shareholder Yield	-21.95%
Earnings Yield	29.19%
FCF Yield	-20.93%

Analyst Forecast

The average price target for CHRS is $5.38, which is 541.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.38
Price Target Difference	541.55%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	8.22%
EPS Growth Forecast (5Y)	18.91%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHRS has an Altman Z-Score of -4.58 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.58
Piotroski F-Score	4